Prevalence and correlates of pregnancy self-testing among pregnant women attending antenatal care in western Kenya.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
12
2020
accepted:
30
09
2021
entrez:
12
11
2021
pubmed:
13
11
2021
medline:
31
12
2021
Statut:
epublish
Résumé
In sub-Saharan Africa little is known about how often women use pregnancy self-tests or characteristics of these women despite evidence that pregnancy self-testing is associated with early antenatal care (ANC) initiation. Understanding the characteristics of women who use pregnancy self-tests can facilitate more targeted efforts to improve pregnancy testing experiences and entry into the ANC pathway. We conducted a cross-sectional survey among pregnant women enrolling in a pre-exposure prophylaxis (PrEP) implementation study to determine the prevalence and factors associated with pregnancy self-testing among women in western Kenya. Overall, in our study population, 17% of women obtained a pregnancy self-test from a pharmacy. Pregnancy test use was higher among employed women, women with secondary and college-level educated partners, and women who spent 30 minutes or less traveling to the maternal and child health (MCH) clinic. The most reported reasons for non-use of pregnancy self-tests included not thinking it was necessary, lack of knowledge, and money to pay for the test. Future research should focus on understanding the knowledge and attitudes of women toward pregnancy self-testing as well as developing community-based models to improve access to pregnancy testing and ANC.
Identifiants
pubmed: 34767573
doi: 10.1371/journal.pone.0258578
pii: PONE-D-20-39327
pmc: PMC8589148
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0258578Subventions
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD100201
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125498
Pays : United States
Déclaration de conflit d'intérêts
JMB reports personal fees from Gilead Sciences, Janssen, and Merck, outside the submitted work. There are no patents, products in development, or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Soc Sci Med. 2000 Aug;51(4):551-61
pubmed: 10868670
J Adv Nurs. 2008 Feb;61(3):244-60
pubmed: 18197860
PLoS One. 2013;8(1):e53747
pubmed: 23335973
Lancet Glob Health. 2017 Oct;5(10):e977-e983
pubmed: 28911763
Health Policy Plan. 2017 Jul 1;32(6):869-881
pubmed: 28387867
Front Public Health. 2019 Jun 25;7:161
pubmed: 31294012
BMC Pregnancy Childbirth. 2006 Aug 07;6:26
pubmed: 16893459
Glob Health Sci Pract. 2013 Sep 16;1(3):372-81
pubmed: 25276550
BMC Health Serv Res. 2017 Jun 19;17(1):416
pubmed: 28629475
Birth. 1991 Mar;18(1):11-3
pubmed: 2006953
Reprod Health. 2017 Nov 15;14(1):150
pubmed: 29141675
Health Policy Plan. 2019 Oct 1;34(8):566-573
pubmed: 31408150
BMJ Open. 2019 Oct 7;9(10):e031890
pubmed: 31594900
BMC Pregnancy Childbirth. 2014 Aug 25;14:287
pubmed: 25154737
Turk J Emerg Med. 2018 Aug 07;18(3):91-93
pubmed: 30191186
BMJ Open. 2019 Mar 7;9(3):e025122
pubmed: 30850409
BJOG. 2017 May;124(6):860-862
pubmed: 28190290
Reprod Health. 2008 Dec 30;5:13
pubmed: 19116011
PLoS One. 2018 May 21;13(5):e0197324
pubmed: 29782511
Soc Sci Med. 2018 Jan;197:104-115
pubmed: 29223685
BMC Health Serv Res. 2012 Jul 27;12:223
pubmed: 22838649